Valproic acid and Crixivan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valproic acid (valproic acid) and Crixivan (indinavir sulfate). Common drug interactions include liver fatty among females and grand mal convulsion among males.

The phase IV clinical study analyzes what interactions people have when they take Valproic acid and Crixivan. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Valproic acid?

Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 36,193 Valproic acid users. Check the latest studies of Valproic acid.

What is Crixivan?

Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

26 people who take Valproic acid and Crixivan together, and have interactions are studied.

Valproic acid and Crixivan drug interactions.

What are the common drug interactions of Valproic Acid and Crixivan, by gender? *:

female:

  1. Liver fatty (fat deposition of liver)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Vomiting
  4. Gamma-glutamyltransferase increased
  5. Lactic acidosis (low ph in body tissues)
  6. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  7. Acidosis (build-up of carbon dioxide in the blood)
  8. Alanine aminotransferase increased
  9. Aspartate aminotransferase increased
  10. Blood alkaline phosphatase nos increased

male:

  1. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  2. Haematocrit increased
  3. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  4. Haemoglobin decreased
  5. Haemoglobin increased
  6. Hypoxia (low oxygen in tissues)
  7. Inflammation
  8. Pain
  9. Vascular anomaly
  10. Anaemia (lack of blood)

What are the common drug interactions of Valproic Acid and Crixivan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Asthma
  3. Blood carbon dioxide decreased
  4. Blood lactate dehydrogenase increased
  5. Cushingoid (obesity and weakening of the muscles)
  6. Dyspnoea (difficult or laboured respiration)
  7. Femur fracture
  8. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  9. Haemoglobin decreased
  10. Haemolytic anaemia (anaemia due to haemolysis)

40-49:

  1. Liver fatty (fat deposition of liver)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Vomiting
  4. Gamma-glutamyltransferase increased
  5. Lactic acidosis (low ph in body tissues)
  6. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  7. Acidosis (build-up of carbon dioxide in the blood)
  8. Alanine aminotransferase increased
  9. Aspartate aminotransferase increased
  10. Blood alkaline phosphatase nos increased

50-59:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  3. Gamma-glutamyltransferase increased
  4. Hypokalaemia (low potassium)
  5. Lymphocyte count increased
  6. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  7. Muscle atrophy (a decrease in the mass of the muscle)
  8. Pleural effusion (water on the lungs)
  9. Recurrent cancer (repeated cancer)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Valproic acid and Crixivan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valproic acid and Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valproic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crixivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valproic acid and indinavir sulfate (the active ingredients of Valproic acid and Crixivan, respectively), and Valproic acid and Crixivan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: